More articles from Study protocols

Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β₂-agonist therapy in patients with asthma: REACH study design
Akio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, Kazuya Sumi, Toshiaki Mikami, Norihiko Kondo

ERJ Open Research Mar 2023, 9 (2) 00452-2022; DOI: 10.1183/23120541.00452-2022
Long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate-to-severe asthma: ATLAS trial design
Lucia De Prado Gomez, Ian Pavord, William Busse, Christopher E. Brightling, Michael E. Wechsler, Klaus F. Rabe, Mei Zhang, Jun Xing, Juby A. Jacob-Nara, Paul J. Rowe

ERJ Open Research Mar 2023, 9 (2) 00417-2022; DOI: 10.1183/23120541.00417-2022
Eradication of early MRSA infection in cystic fibrosis: a novel study design for the STAR-ter trial
Fiona Cunningham, Ellen Caldwell, Nicole Mayer-Hamblett, Christopher H. Goss, Marianne S. Muhlebach

ERJ Open Research Oct 2022, 8 (4) 00190-2022; DOI: 10.1183/23120541.00190-2022
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps
Shahid Siddiqui, Claus Bachert, Adam M. Chaker, Joseph K. Han, Peter W. Hellings, Anju T. Peters, Enrico Heffler, Siddhesh Kamat, Haixin Zhang, Scott Nash, Asif H. Khan, Lucia De Prado Gomez, Juby A. Jacob-Nara, Paul J. Rowe, Yamo Deniz

ERJ Open Research Oct 2022, 8 (4) 00085-2022; DOI: 10.1183/23120541.00085-2022
The disease-specific clinical trial network for primary ciliary dyskinesia: PCD-CTN
Johanna Raidt, Bernard Maitre, Petra Pennekamp, Josje Altenburg, Pinelopi Anagnostopoulou, Miguel Armengot, Lizan D. Bloemsma, Mieke Boon, Melissa Borrelli, Folke Brinkmann, Siobhan B. Carr, Mary P. Carroll, Silvia Castillo-Corullón, André Coste, Renato Cutrera, Eleonora Dehlink, Damien M.S. Destouches, Maria E. Di Cicco, Lucy Dixon, Nagehan Emiralioglu, Ela Erdem Eralp, Eric G. Haarman, Claire Hogg, Bulent Karadag, Helene E. Kobbernagel, Natalie Lorent, Marcus A. Mall, June K. Marthin, Vendula Martinu, Manjith Narayanan, Ugur Ozcelik, Daniel Peckham, Massimo Pifferi, Petr Pohunek, Eva Polverino, Simon Range, Felix C. Ringshausen, Evie Robson, Jobst Roehmel, Sandra Rovira-Amigo, Francesca Santamaria, Anne Schlegtendal, Zsolt Szépfalusi, Petra Tempels, Guillaume Thouvenin, Nicola Ullmann, Woolf T. Walker, Martin Wetzke, Panayiotis Yiallouros, Heymut Omran, Kim G. Nielsen

ERJ Open Research Jul 2022, 8 (3) 00139-2022; DOI: 10.1183/23120541.00139-2022
Impact of wait times for treatment on clinical outcomes in patients with obstructive sleep apnoea: protocol for a randomised controlled trial
Christina S. Thornton, Marcus Povitz, Willis H. Tsai, Andrea H. Loewen, Ada Ip-Buting, Tetyana Kendzerska, W. Ward Flemons, Kristin L. Fraser, Patrick J. Hanly, Sachin R. Pendharkar

ERJ Open Research Apr 2022, 8 (2) 00068-2022; DOI: 10.1183/23120541.00068-2022
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
Lee Hatter, Pepa Bruce, Mark Holliday, Augustus J. Anderson, Irene Braithwaite, Andrew Corin, Allie Eathorne, Arthur Grimes, Matire Harwood, Thomas Hills, Ciléin Kearns, Kyley Kerse, John Martindale, Barney Montgomery, Lynn Riggs, Davitt Sheahan, Nick Shortt, Katja Zazulia, Mark Weatherall, David McNamara, Catherine A. Byrnes, Andrew Bush, Stuart R. Dalziel, Richard Beasley

ERJ Open Research Oct 2021, 7 (4) 00271-2021; DOI: 10.1183/23120541.00271-2021
Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale
Zhenyu Liang, Nanshan Zhong, Rongchang Chen, Qianli Ma, Yongchang Sun, Fuqiang Wen, Ruth Tal-Singer, Bruce E. Miller, Julie Yates, Jie Song, Chris Compton, Beulah Ji, Li Wu, Yang Yang, Paul Jones, Jinping Zheng

ERJ Open Research Jul 2021, 7 (3) 00201-2021; DOI: 10.1183/23120541.00201-2021
Study design of a randomised, placebo-controlled trial of nintedanib in children and adolescents with fibrosing interstitial lung disease
Robin Deterding, Matthias Griese, Gail Deutsch, David Warburton, Emily M. DeBoer, Steven Cunningham, Annick Clement, Nicolaus Schwerk, Kevin R. Flaherty, Kevin K. Brown, Florian Voss, Ulrike Schmid, Rozsa Schlenker-Herceg, Daniela Verri, Mihaela Dumistracel, Marilisa Schiwek, Susanne Stowasser, Kay Tetzlaff, Emmanuelle Clerisme-Beaty, Lisa R. Young

ERJ Open Research Apr 2021, 7 (2) 00805-2020; DOI: 10.1183/23120541.00805-2020
Design and rationale of a randomised, double-blind trial of the efficacy and safety of pirfenidone in patients with fibrotic hypersensitivity pneumonitis
Evans R. Fernández Pérez, James L. Crooks, Jeffrey J. Swigris, Joshua J. Solomon, Michael P. Mohning, Tristan J. Huie, Matthew Koslow, David A. Lynch, Steve D. Groshong, Kaitlin Fier

ERJ Open Research Apr 2021, 7 (2) 00054-2021; DOI: 10.1183/23120541.00054-2021

Main menu

User menu

Search

More articles from Study protocols

Pages

Contact us